Heart Drug Finerenone Shows Promise for Preventing Dangerous Irregular Heartbeat
New research reveals finerenone may reduce new-onset atrial fibrillation in heart failure patients with preserved ejection fraction.
Cardiovascular health, heart failure, atherosclerosis, and cardiac research
421 artigos
New research reveals finerenone may reduce new-onset atrial fibrillation in heart failure patients with preserved ejection fraction.
New analysis reveals oral semaglutide significantly reduces cardiovascular risk factors beyond blood sugar control in type 2 diabetes.
Major study analyzes survival outcomes when cardiac arrest complicates heart attack shock, revealing key patterns for emergency care.
New 20-year analysis reveals stark disparities in blood pressure control worldwide, with low-income countries falling further behind.
Advanced cardiac troponin test demonstrates improved sensitivity for detecting heart attacks in emergency settings.
New research reveals GLP-1 receptor agonists could significantly reduce cardiovascular risk in broader patient populations.
Revolutionary approach moves beyond traditional risk assessment to target specific biological mechanisms driving heart disease.
New framework could help doctors better identify and treat primary aldosteronism, a leading cause of high blood pressure.
Online cognitive behavioral therapy significantly improved disease-specific health status in heart attack survivors with cardiac anxiety.
Breakthrough treatment works through multiple mechanisms beyond the lungs, enhancing oxygen delivery and muscle function.
CRISPR gene therapy shows promise for curing genetic heart diseases like high cholesterol and amyloidosis with one-time treatments.
New research shows cardiac MRI significantly enhances success rates for treating life-threatening heart rhythm disorders.